GAit, MEmory, Dietary and Vitamin D

NCT ID: NCT02086409

Last Updated: 2016-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gait and posture disorders are very common in subjects aged 65 and over, and result mainly from neuromuscular and cognitive disorders.

Many studies have shown that 1) vitamin D deficiency is very common in women aged 65 and over, 2) individuals with hypovitaminosis D have lower muscle, gait and executive performances and are more prone to fail than individuals with no hypovitaminosis D, 3) the intake of vitamin D combined or not with calcium may improve muscle strength and cognitive performance.

The investigators hypothesized that the daily intake of 2 yogurts containing 200 IU of vitamin D and 400 mg of calcium 1) can improve spatiotemporal gait parameters, posture and executive performance, 2) and that this improvement depends of the initial level of vitamin D deficiency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Memory Complaint Without Cognitive Decline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Yogurt supplemented with vitamin D and calcium

20 participants take yogurt supplemented with vitamin D and calcium during 12 weeks

Group Type EXPERIMENTAL

Yogurt supplemented with vitamin D and calcium

Intervention Type DIETARY_SUPPLEMENT

The product is a yogurt containing 200 IU of vitamin D and 400 mg of calcium. Participants take 2 yogurts per day.

Yogurt not supplemented with vitamin D and calcium

20 participants take yogurt not supplemented with vitamin D and calcium during 12 weeks

Group Type ACTIVE_COMPARATOR

Yogurt not supplemented with vitamin D and calcium

Intervention Type DIETARY_SUPPLEMENT

The comparator is represented by a yogurt not supplemented with vitamin D and calcium.Participants take 2 yogurts per day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yogurt supplemented with vitamin D and calcium

The product is a yogurt containing 200 IU of vitamin D and 400 mg of calcium. Participants take 2 yogurts per day.

Intervention Type DIETARY_SUPPLEMENT

Yogurt not supplemented with vitamin D and calcium

The comparator is represented by a yogurt not supplemented with vitamin D and calcium.Participants take 2 yogurts per day.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Woman aged 65 and over
* To have hypovitaminosis D (i.e. serum 25-hydroxyvitamin D \[25OHD\] concentration ≤ 30ng/mL)
* To have no hypercalcemia (defined as serum calcium concentration ≥ 2,65mmol/L)
* Ability to walk a distance of 15 meters unaided
* Ability to eat 2 yogurts per day
* Memory complaint without cognitive decline
* To have given and signed an informed consent to participate in the trial
* To be affiliated to French Social Security
* To have no vitamin D supplementation during inclusion

Exclusion Criteria

* Existence of dementia according to DSM-IV and NINCDS-ADRDA criteria and others cognitive disorders: untreated thyroid dysfunction, chronic ongoing ethylism, history of syphilis, stroke with sequelae, depressive symptomatology (Geriatric Depression Scale \> 5/15)
* Osteoarticular diseases of the lower members and / or spine altering the biomechanical characteristics of the body.
* Vitamin D supplementation during inclusion
* Contraindications to vitamin D
* Unstable medical condition
* Dairy allergy
* Taste of dairy products not supported
* Enrolment in another simultaneous clinical trial
* Civil defense measures underway
* Refusal to participate of the subject
Minimum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire d'Angers

Angers, Maine et Loire, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A01499-36

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Functionality in Older People
NCT03611049 TERMINATED PHASE2
Treatment of Vitamin D Insufficiency
NCT00933244 COMPLETED PHASE4